SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001932
Filing Date
2021-02-26
Accepted
2021-02-26 09:36:00
Documents
83
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atre-20201231x10k.htm 10-K 2401035
2 EX-23.1 atre-20201231ex23199b430.htm EX-23.1 2559
3 EX-31.1 atre-20201231ex3115b16d3.htm EX-31.1 11375
4 EX-31.2 atre-20201231ex3123206c5.htm EX-31.2 11264
5 EX-32.1 atre-20201231ex321e3031c.htm EX-32.1 8398
6 GRAPHIC atre-20201231x10k006.jpg GRAPHIC 19260
7 GRAPHIC atre-20201231x10k007.jpg GRAPHIC 18734
8 GRAPHIC atre-20201231x10k008.jpg GRAPHIC 35285
  Complete submission text file 0001558370-21-001932.txt   8690198

Data Files

Seq Description Document Type Size
9 EX-101.INS atre-20201231.xml EX-101.INS 1862832
10 EX-101.SCH atre-20201231.xsd EX-101.SCH 49415
11 EX-101.CAL atre-20201231_cal.xml EX-101.CAL 63943
12 EX-101.DEF atre-20201231_def.xml EX-101.DEF 235983
13 EX-101.LAB atre-20201231_lab.xml EX-101.LAB 441257
14 EX-101.PRE atre-20201231_pre.xml EX-101.PRE 412532
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38935 | Film No.: 21684251
SIC: 2834 Pharmaceutical Preparations